Pfizer [PFIZER] vs Sanofi India Limited [SANOFI] Detailed Stock Comparison
Pfizer
NSE
Loading...
Sanofi India Limited
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pfizer wins in 11 metrics, Sanofi India Limited wins in 9 metrics, with 0 ties. Pfizer appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pfizer | Sanofi India Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.68 | 32.51 | Pfizer |
| Price-to-Book Ratio | 5.69 | 15.05 | Pfizer |
| Debt-to-Equity Ratio | 2.57 | 2.67 | Pfizer |
| PEG Ratio | 1.09 | -1.00 | Sanofi India Limited |
| EV/EBITDA | 28.90 | 22.96 | Sanofi India Limited |
| Profit Margin (TTM) | 34.83% | 18.29% | Pfizer |
| Operating Margin (TTM) | 32.44% | 21.12% | Pfizer |
| EBITDA Margin (TTM) | 32.44% | 21.12% | Pfizer |
| Return on Equity | 18.20% | 49.43% | Sanofi India Limited |
| Return on Assets (TTM) | 15.63% | 22.47% | Sanofi India Limited |
| Free Cash Flow (TTM) | $6.32B | $4.25B | Pfizer |
| Dividend Yield | 1.27% | 1.93% | Sanofi India Limited |
| 1-Year Return | -14.79% | -24.95% | Pfizer |
| Price-to-Sales Ratio (TTM) | 10.35 | 5.94 | Sanofi India Limited |
| Enterprise Value | $213.39B | $114.62B | Pfizer |
| EV/Revenue Ratio | 9.19 | 5.79 | Sanofi India Limited |
| Gross Profit Margin (TTM) | 64.97% | 48.63% | Pfizer |
| Revenue per Share (TTM) | $507 | $860 | Sanofi India Limited |
| Earnings per Share (Diluted) | $176.89 | $157.20 | Pfizer |
| Beta (Stock Volatility) | 0.13 | 0.08 | Sanofi India Limited |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pfizer vs Sanofi India Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pfizer | -0.23% | -8.64% | -2.09% | -5.83% | 28.11% | -2.22% |
| Sanofi India Limited | 0.67% | -3.19% | -11.88% | -17.82% | 1.82% | -16.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pfizer | -14.79% | 21.34% | 8.24% | 123.32% | 367.35% | 547.13% |
| Sanofi India Limited | -24.95% | -16.54% | -39.22% | 31.24% | 183.72% | 244.79% |
Performance & Financial Health Analysis: Pfizer vs Sanofi India Limited
| Metric | PFIZER | SANOFI |
|---|---|---|
| Market Information | ||
| Market Cap | ₹240.18B | ₹117.69B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 113,572 | 11,669 |
| 90 Day Avg. Volume | 50,263 | 11,166 |
| Last Close | ₹5,156.00 | ₹5,144.00 |
| 52 Week Range | ₹3,701.00 - ₹6,451.15 | ₹4,902.00 - ₹7,600.00 |
| % from 52W High | -20.08% | -32.32% |
| All-Time High | ₹6,451.15 (Sep 02, 2024) | ₹10,524.95 (Jun 10, 2024) |
| % from All-Time High | -20.08% | -51.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | -0.12% |
| Quarterly Earnings Growth | 0.27% | -0.33% |
| Financial Health | ||
| Profit Margin (TTM) | 0.35% | 0.18% |
| Operating Margin (TTM) | 0.32% | 0.21% |
| Return on Equity (TTM) | 0.18% | 0.49% |
| Debt to Equity (MRQ) | 2.57 | 2.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹921.88 | ₹339.62 |
| Cash per Share (MRQ) | ₹608.26 | ₹135.75 |
| Operating Cash Flow (TTM) | ₹9.08B | ₹3.90B |
| Levered Free Cash Flow (TTM) | ₹7.68B | ₹2.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.27% | 1.93% |
| Last 12-Month Dividend | ₹70.00 | ₹117.00 |
Valuation & Enterprise Metrics Analysis: Pfizer vs Sanofi India Limited
| Metric | PFIZER | SANOFI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.68 | 32.51 |
| Forward P/E | 31.36 | 25.08 |
| PEG Ratio | 1.09 | -1.00 |
| Price to Sales (TTM) | 10.35 | 5.94 |
| Price to Book (MRQ) | 5.69 | 15.05 |
| Market Capitalization | ||
| Market Capitalization | ₹240.18B | ₹117.69B |
| Enterprise Value | ₹213.39B | ₹114.62B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.19 | 5.79 |
| Enterprise to EBITDA | 28.90 | 22.96 |
| Risk & Other Metrics | ||
| Beta | 0.13 | 0.08 |
| Book Value per Share (MRQ) | ₹921.88 | ₹339.62 |
Financial Statements Comparison: Pfizer vs Sanofi India Limited
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PFIZER | SANOFI |
|---|---|---|
| Revenue/Sales | ₹6.03B | ₹5.36B |
| Cost of Goods Sold | ₹2.11B | ₹2.41B |
| Gross Profit | ₹3.92B | ₹2.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹1.96B | ₹1.62B |
| EBITDA | ₹2.77B | ₹1.75B |
| Pre-Tax Income | ₹2.60B | ₹1.65B |
| Income Tax | ₹677.80M | ₹458.00M |
| Net Income (Profit) | ₹1.92B | ₹1.20B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PFIZER | SANOFI |
|---|---|---|
| Cash & Equivalents | ₹4.95B | ₹2.84B |
| Total Current Assets | ₹35.13B | ₹11.27B |
| Total Current Liabilities | ₹5.70B | ₹7.19B |
| Long-Term Debt | ₹676.20M | ₹140.00M |
| Total Shareholders Equity | ₹42.17B | ₹8.61B |
| Retained Earnings | ₹24.36B | ₹4.46B |
| Property, Plant & Equipment | ₹1.72B | ₹3.11B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PFIZER | SANOFI |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PFIZER | SANOFI |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 113,572 | 11,669 |
| Average Daily Volume (90 Day) | 50,263 | 11,166 |
| Shares Outstanding | 45.75M | 23.03M |
| Float Shares | 15.12M | 9.07M |
| % Held by Insiders | 0.67% | 0.61% |
| % Held by Institutions | 0.17% | 0.26% |
Dividend Analysis & Yield Comparison: Pfizer vs Sanofi India Limited
| Metric | PFIZER | SANOFI |
|---|---|---|
| Last 12-Month Dividend | ₹70.00 | ₹117.00 |
| Last 12-Month Dividend Yield | 1.27% | 1.93% |
| 3-Year Avg Annual Dividend | ₹46.67 | ₹220.00 |
| 3-Year Avg Dividend Yield | 0.58% | 2.07% |
| 3-Year Total Dividends | ₹140.00 | ₹660.00 |
| Ex-Dividend Date | Jul 09, 2025 | Apr 25, 2025 |